Cargando…
Exploring Cefiderocol Resistance Mechanisms in Burkholderia pseudomallei
Cefiderocol is a siderophore cephalosporin designed mainly for treatment of infections caused by β-lactam and multidrug-resistant Gram-negative bacteria. Burkholderia pseudomallei clinical isolates are usually highly cefiderocol susceptible, with in vitro resistance found in a few isolates. Resistan...
Autores principales: | Hall, Carina M., Somprasong, Nawarat, Hagen, Johannah P., Nottingham, Roxanne, Sahl, Jason W., Webb, Jessica R., Mayo, Mark, Currie, Bart J., Podin, Yuwana, Wagner, David M., Keim, Paul, Schweizer, Herbert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269091/ https://www.ncbi.nlm.nih.gov/pubmed/37133377 http://dx.doi.org/10.1128/aac.00171-23 |
Ejemplares similares
-
Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria
por: Somprasong, Nawarat, et al.
Publicado: (2020) -
Evaluation of Delafloxacin against a Burkholderia pseudomallei Efflux Mutant Panel
por: McCurdy, Sandra P., et al.
Publicado: (2022) -
New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae
por: Nurjadi, Dennis, et al.
Publicado: (2022) -
The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae
por: Zhang, Ping, et al.
Publicado: (2023) -
In Vitro Activity of a Novel Glycopolymer against Biofilms of Burkholderia cepacia Complex Cystic Fibrosis Clinical Isolates
por: Narayanaswamy, Vidya P., et al.
Publicado: (2019)